Candel Therapeutics, Inc. (CADL) Reports Q2 Loss of $0.74/sh

Go back to Candel Therapeutics, Inc. (CADL) Reports Q2 Loss of $0.74/sh
(NASDAQ: CADL) Delayed: 10.85 --0 (-0%)
Previous Close $10.85    52 Week High
Open $10.85    52 Week Low
Day High $10.85    P/E N/A 
Day Low $10.85    EPS
Volume 3,737